Eutylone

β-Keto-1,3-benzodioxolyl-N-ethylbutanamine is a stimulant and empathogenic compound developed in the 1960s, which has been reported as a novel designer drug, first being reported to the EMCDDA in 2014 but becoming widespread internationally in 2019-2020 following bans on the related compound ephylone.


β-Keto-1,3-benzodioxolyl-N-ethylbutanamine is a stimulant and empathogenic compound developed in the 1960s, which has been reported as a novel designer drug, first being reported to the EMCDDA in 2014 but becoming widespread internationally in 2019-2020 following bans on the related compound ephylone.
Read article on Wikipedia